Global Market Report

Global Neurological Biomarkers Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 28, 2019
  • PAGES：174
  • REPORT CODE：GMM176980
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Neurological Biomarkers witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Neurological Biomarkers market is offered. The research provides insights for the global Neurological Biomarkers market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Neurological Biomarkers industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Neurological Biomarkers Market Segmentations:

    By Players:

    • Banyan Biomarkers (U.S.)

    • Proteosys (Germany)

    • Alseres Pharmaceuticals (U.S.)

    • Cisbio Bioassays (U.S.)

    • Acumen Pharmaceuticals (U.S.)

    • Thermo Fisher Scientific (U.S.)

    • Qiagen (Germany)

    • Proteome Sciences (UK)

    • Myriad RBM (U.S.)

    • Abiant (U.S.)


    By Types:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Neurological Biomarkers Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Neurological Biomarkers Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Biomarkers Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Neurological Biomarkers Market Share by Types

      • 1.3.2 Global Neurological Biomarkers Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.3 Global Neurological Biomarkers Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.4 Global Neurological Biomarkers Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Neurological Biomarkers Market Share by End-Users

      • 1.4.2 Global Neurological Biomarkers Market Size and Growth Rate of End-User 1 from 2014 to 2026

      • 1.4.3 Global Neurological Biomarkers Market Size and Growth Rate of End-User 2 from 2014 to 2026

      • 1.4.4 Global Neurological Biomarkers Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumNeurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Neurological Biomarkers Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurological Biomarkers by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of Neurological Biomarkers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurological Biomarkers by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurological Biomarkers for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Neurological Biomarkers for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Neurological Biomarkers for End-Users 3


    5 Market Analysis by Major Regions

    • 5.1 Global Neurological Biomarkers Production Analysis by Major Regions

    • 5.2 Global Neurological Biomarkers Consumption Analysis by Major Regions

    • 5.3 Global Neurological Biomarkers Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Neurological Biomarkers Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Neurological Biomarkers Production, Import, Consumption and Export Analysis


    6 Product Commodity of Neurological Biomarkers Market in Major Countries

    • 6.1 Top 5 Export Countries in Neurological Biomarkers market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Neurological Biomarkers market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Neurological Biomarkers market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neurological Biomarkers market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Neurological Biomarkers market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Neurological Biomarkers market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Neurological Biomarkers Landscape Analysis

    • 7.1 North America Neurological Biomarkers Landscape Analysis by Major Types

    • 7.2 North America Neurological Biomarkers Landscape Analysis by Major End-Users

    • 7.3 North America Neurological Biomarkers Landscape Analysis by Major Countries

      • 7.3.1 United States Neurological Biomarkers Market Volume and Growth Rate

      • 7.3.2 Canada Neurological Biomarkers Market Volume and Growth Rate

      • 7.3.3 Mexico Neurological Biomarkers Market Volume and Growth Rate


    8 Europe Neurological Biomarkers Landscape Analysis

    • 8.1 Europe Neurological Biomarkers Landscape Analysis by Major Types

    • 8.2 Europe Neurological Biomarkers Landscape Analysis by Major End-Users

    • 8.3 Europe Neurological Biomarkers Landscape Analysis by Major Countries

      • 8.3.1 Germany Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.2 UK Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.3 France Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.4 Italy Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.6 Spain Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.7 Belgium Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.8 Poland Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.9 Russia Neurological Biomarkers Market Volume and Growth Rate

      • 8.3.10 Turkey Neurological Biomarkers Market Volume and Growth Rate


    9 Asia Pacific Neurological Biomarkers Landscape Analysis

    • 9.1 Asia Pacific Neurological Biomarkers Landscape Analysis by Major Types

    • 9.2 Asia Pacific Neurological Biomarkers Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Neurological Biomarkers Landscape Analysis by Major Countries

      • 9.3.1 China Neurological Biomarkers Market Volume and Growth Rate

      • 9.3.2 Japan Neurological Biomarkers Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Neurological Biomarkers Market Volume and Growth Rate

      • 9.3.4 India Neurological Biomarkers Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Neurological Biomarkers Market Volume and Growth Rate

      • 9.3.6 South Korea Neurological Biomarkers Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Neurological Biomarkers Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Neurological Biomarkers Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Neurological Biomarkers Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Neurological Biomarkers Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Neurological Biomarkers Market Volume and Growth Rate

      • 10.3.2 Brazil Neurological Biomarkers Market Volume and Growth Rate

      • 10.3.3 Nigeria Neurological Biomarkers Market Volume and Growth Rate

      • 10.3.4 South Africa Neurological Biomarkers Market Volume and Growth Rate 

      • 10.3.5 Argentina Neurological Biomarkers Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Banyan Biomarkers (U.S.)

      • 11.1.1 Banyan Biomarkers (U.S.) Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Proteosys (Germany)

      • 11.2.1 Proteosys (Germany) Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Alseres Pharmaceuticals (U.S.)

      • 11.3.1 Alseres Pharmaceuticals (U.S.) Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Cisbio Bioassays (U.S.)

      • 11.4.1 Cisbio Bioassays (U.S.) Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Acumen Pharmaceuticals (U.S.)

      • 11.5.1 Acumen Pharmaceuticals (U.S.) Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Thermo Fisher Scientific (U.S.)

      • 11.6.1 Thermo Fisher Scientific (U.S.) Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Qiagen (Germany)

      • 11.7.1 Qiagen (Germany) Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Proteome Sciences (UK)

      • 11.8.1 Proteome Sciences (UK) Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Myriad RBM (U.S.)

      • 11.9.1 Myriad RBM (U.S.) Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Abiant (U.S.)

      • 11.10.1 Abiant (U.S.) Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 87 Figures and 154 Tables)

    • Figure Product Picture

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Neurological Biomarkers Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neurological Biomarkers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neurological Biomarkers

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurological Biomarkers by Different Types from 2014 to 2026

    • Table Consumption Share of Neurological Biomarkers by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neurological Biomarkers by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neurological Biomarkers by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global Neurological Biomarkers Production by Major Regions

    • Table Global Neurological Biomarkers Production Share by Major Regions

    • Figure Global Neurological Biomarkers Production Share by Major Regions in 2014

    • Figure Global Neurological Biomarkers Production Share by Major Regions in 2018

    • Figure Global Neurological Biomarkers Production Share by Major Regions in 2026

    • Table Global Neurological Biomarkers Consumption by Major Regions

    • Table Global Neurological Biomarkers Consumption Share by Major Regions

    • Figure Global Neurological Biomarkers Consumption Share by Major Regions in 2014

    • Figure Global Neurological Biomarkers Consumption Share by Major Regions in 2018

    • Figure Global Neurological Biomarkers Consumption Share by Major Regions in 2026

    • Table North America Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Europe Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neurological Biomarkers market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neurological Biomarkers market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neurological Biomarkers market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neurological Biomarkers market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table North America Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure North America Neurological Biomarkers Consumption Share by Types in 2014

    • Figure North America Neurological Biomarkers Consumption Share by Types in 2018

    • Figure North America Neurological Biomarkers Consumption Share by Types in 2026

    • Table North America Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table North America Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure North America Neurological Biomarkers Consumption Share by End-Users in 2014

    • Figure North America Neurological Biomarkers Consumption Share by End-Users in 2018

    • Figure North America Neurological Biomarkers Consumption Share by End-Users in 2026

    • Table North America Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table North America Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Neurological Biomarkers Consumption Share by Major Countries in 2014

    • Figure North America Neurological Biomarkers Consumption Share by Major Countries in 2018

    • Figure North America Neurological Biomarkers Consumption Share by Major Countries in 2026

    • Figure United States Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Europe Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Europe Neurological Biomarkers Consumption Share by Types in 2014

    • Figure Europe Neurological Biomarkers Consumption Share by Types in 2018

    • Figure Europe Neurological Biomarkers Consumption Share by Types in 2026

    • Table Europe Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Europe Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Neurological Biomarkers Consumption Share by End-Users in 2014

    • Figure Europe Neurological Biomarkers Consumption Share by End-Users in 2018

    • Figure Europe Neurological Biomarkers Consumption Share by End-Users in 2026

    • Table Europe Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Europe Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Neurological Biomarkers Consumption Share by Major Countries in 2014

    • Figure Europe Neurological Biomarkers Consumption Share by Major Countries in 2018

    • Figure Europe Neurological Biomarkers Consumption Share by Major Countries in 2026

    • Figure Germany Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure France Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Asia Pacific Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Types in 2014

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Types in 2018

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Types in 2026

    • Table Asia Pacific Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by End-Users in 2014

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by End-Users in 2018

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by End-Users in 2026

    • Table Asia Pacific Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Neurological Biomarkers Consumption Share by Major Countries in 2026

    • Figure China Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNeurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure India Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Neurological Biomarkers Consumption Share by Major Countries in 2026

    • Figure GCC Countries Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Banyan Biomarkers (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Banyan Biomarkers (U.S.)

    • Figure Sales and Growth Rate Analysis of Banyan Biomarkers (U.S.)

    • Figure Revenue and Market Share Analysis of Banyan Biomarkers (U.S.)

    • Table Product and Service Introduction of Banyan Biomarkers (U.S.)

    • Table Company Profile and Development Status of Proteosys (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Proteosys (Germany)

    • Figure Sales and Growth Rate Analysis of Proteosys (Germany)

    • Figure Revenue and Market Share Analysis of Proteosys (Germany)

    • Table Product and Service Introduction of Proteosys (Germany)

    • Table Company Profile and Development Status of Alseres Pharmaceuticals (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alseres Pharmaceuticals (U.S.)

    • Figure Sales and Growth Rate Analysis of Alseres Pharmaceuticals (U.S.)

    • Figure Revenue and Market Share Analysis of Alseres Pharmaceuticals (U.S.)

    • Table Product and Service Introduction of Alseres Pharmaceuticals (U.S.)

    • Table Company Profile and Development Status of Cisbio Bioassays (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cisbio Bioassays (U.S.)

    • Figure Sales and Growth Rate Analysis of Cisbio Bioassays (U.S.)

    • Figure Revenue and Market Share Analysis of Cisbio Bioassays (U.S.)

    • Table Product and Service Introduction of Cisbio Bioassays (U.S.)

    • Table Company Profile and Development Status of Acumen Pharmaceuticals (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acumen Pharmaceuticals (U.S.)

    • Figure Sales and Growth Rate Analysis of Acumen Pharmaceuticals (U.S.)

    • Figure Revenue and Market Share Analysis of Acumen Pharmaceuticals (U.S.)

    • Table Product and Service Introduction of Acumen Pharmaceuticals (U.S.)

    • Table Company Profile and Development Status of Thermo Fisher Scientific (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific (U.S.)

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific (U.S.)

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific (U.S.)

    • Table Product and Service Introduction of Thermo Fisher Scientific (U.S.)

    • Table Company Profile and Development Status of Qiagen (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen (Germany)

    • Figure Sales and Growth Rate Analysis of Qiagen (Germany)

    • Figure Revenue and Market Share Analysis of Qiagen (Germany)

    • Table Product and Service Introduction of Qiagen (Germany)

    • Table Company Profile and Development Status of Proteome Sciences (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Proteome Sciences (UK)

    • Figure Sales and Growth Rate Analysis of Proteome Sciences (UK)

    • Figure Revenue and Market Share Analysis of Proteome Sciences (UK)

    • Table Product and Service Introduction of Proteome Sciences (UK)

    • Table Company Profile and Development Status of Myriad RBM (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad RBM (U.S.)

    • Figure Sales and Growth Rate Analysis of Myriad RBM (U.S.)

    • Figure Revenue and Market Share Analysis of Myriad RBM (U.S.)

    • Table Product and Service Introduction of Myriad RBM (U.S.)

    • Table Company Profile and Development Status of Abiant (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abiant (U.S.)

    • Figure Sales and Growth Rate Analysis of Abiant (U.S.)

    • Figure Revenue and Market Share Analysis of Abiant (U.S.)

    • Table Product and Service Introduction of Abiant (U.S.)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US